According to the revised AD criteria by the Alzheimer’s Association Workgroup, plasma p-tau217 is a core 1 biomarker (T1) of phosphorylated and secreted AD tau, while tau-PET is a core 2 biomarker (T2) of AD tau proteinopathy32. This evidence concerns the gene MAPT and Alzheimer disease.